NP
ELV icon

NorthRock Partners’s Elevance Health ELV Stock Holding History

NorthRock Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$355K Sell
917
-315
-26% -$117K 0.01% 500
2026
Q1 		$361K Buy
1,232
+499
+68% +$164K 0.01% 477
2025
Q4 		$257K Sell
733
-1,777
-71% -$601K ﹤0.01% 509
2025
Q3 		$811K Buy
2,510
+293
+13% +$91.1K 0.01% 392
2025
Q2 		$862K Sell
2,217
-13
-0.6% -$5.23K 0.02% 271
2025
Q1 		$970K Buy
2,230
+158
+8% +$63.4K 0.03% 214
2024
Q4 		$764K Sell
2,072
-6
-0.3% -$2.51K 0.02% 253
2024
Q3 		$1.08M Buy
2,078
+45
+2% +$24K 0.04% 200
2024
Q2 		$1.1M Buy
2,033
+94
+5% +$49.7K 0.04% 184
2024
Q1 		$1.01M Buy
1,939
+182
+10% +$90.5K 0.04% 202
2023
Q4 		$829K Buy
1,757
+751
+75% +$347K 0.03% 220
2023
Q3 		$438K Buy
1,006
+196
+24% +$88.9K 0.05% 178
2023
Q2 		$360K Sell
810
-234
-22% -$108K 0.04% 184
2023
Q1 		$480K Sell
1,044
-290
-22% -$138K 0.05% 158
2022
Q4 		$684K Buy
1,334
+204
+18% +$104K 0.08% 125
2022
Q3 		$513K Buy
1,130
+137
+14% +$65.6K 0.06% 138
2022
Q2 		$479K Buy
993
+75
+8% +$37.1K 0.05% 160
2022
Q1 		$451K Sell
918
-41
-4% -$18.7K 0.04% 188
2021
Q4 		$444K Buy
959
+391
+69% +$164K 0.03% 190
2021
Q3 		$240K Buy
+568
New +$216K 0.02% 245

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

NorthRock Partners's ELV Position: Q2 2026 in Review

NorthRock Partners reduced its Elevance Health (ELV) stake by 26% in Q2 2026, selling an estimated $117K and leaving 917 shares worth $355K. The position accounts for 0.01% of the portfolio, ranked #500.

NorthRock Partners first reported a position in ELV in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.1M in Q2 2024. 1,198 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • NorthRock Partners held 917 shares of Elevance Health worth $355K as of Q2 2026.
  • NorthRock Partners sold 315 Elevance Health shares in Q2 2026, an estimated $117K.
  • Elevance Health made up 0.01% of NorthRock Partners's portfolio in Q2 2026, its #500 holding.
  • NorthRock Partners first reported a position in Elevance Health in Q3 2021 and has held it in 20 quarters since.
  • NorthRock Partners's Elevance Health position peaked at $1.1M in Q2 2024.
  • 1,198 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on NorthRock Partners's 13F filing for Q2 2026, filed 11 Aug 2026.